Tohru Mizushima is conducting research in Pseudomonas aeruginosa, Antibacterial agent and Staphylococcus aureus as part of his Bacteria study. His Antibacterial agent study frequently intersects with other fields, such as Antibiotics. In his works, he performs multidisciplinary study on Antibiotics and Drug resistance. In his research, Tohru Mizushima undertakes multidisciplinary study on Drug resistance and Multiple drug resistance. While working in this field, he studies both Staphylococcus aureus and Bacteria. Tohru Mizushima performs integrative study on Biochemistry and Immunology. In his study, he carries out multidisciplinary Immunology and Biochemistry research. His research combines Pseudomonas aeruginosa and Genetics. Many of his studies involve connections with topics such as Transporter and Gene.
His research on Biochemistry frequently links to adjacent areas such as In vitro. Tohru Mizushima incorporates Gene and Mutant in his studies. Tohru Mizushima undertakes multidisciplinary studies into Pharmacology and Biochemistry in his work. In his works, he conducts interdisciplinary research on Molecular biology and Plasmid. His work blends Plasmid and Molecular biology studies together. Tohru Mizushima conducted interdisciplinary study in his works that combined Genetics and Bacteria. He connects Bacteria with Genetics in his research. He merges DNA with Escherichia coli in his study. In his study, Tohru Mizushima carries out multidisciplinary Escherichia coli and DNA research.
His Chemotherapy research spans across into fields like Bleomycin and Cancer research. Tohru Mizushima merges Bleomycin with Pulmonary fibrosis in his study. His work blends Pulmonary fibrosis and Idiopathic pulmonary fibrosis studies together. He conducts interdisciplinary study in the fields of Cancer research and Chemotherapy through his research. In his works, he undertakes multidisciplinary study on Pharmacology and Pathology. He brings together Pathology and Pharmacology to produce work in his papers. He integrates Internal medicine and Endocrinology in his research. He undertakes multidisciplinary studies into Endocrinology and Internal medicine in his work. He integrates many fields in his works, including Biochemistry and Organic chemistry.
In his papers, Tohru Mizushima integrates diverse fields, such as Pharmacology and Biochemistry. He integrates Biochemistry and Pharmacology in his studies. His Bleomycin research extends to Internal medicine, which is thematically connected. His study deals with a combination of Bleomycin and Pulmonary fibrosis. Tohru Mizushima connects Pulmonary fibrosis with Idiopathic pulmonary fibrosis in his study. He combines Idiopathic pulmonary fibrosis and Lung in his research. He conducts interdisciplinary study in the fields of Lung and ARDS through his research. He undertakes interdisciplinary study in the fields of ARDS and Pulmonary edema through his research. He combines Pulmonary edema and Edema in his research.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
NorM, a Putative Multidrug Efflux Protein, of Vibrio parahaemolyticus and Its Homolog in Escherichia coli
Yuji Morita;Kazuyo Kodama;Sumiko Shiota;Tomoyuki Mine.
Antimicrobial Agents and Chemotherapy (1998)
Endoplasmic reticulum stress response is involved in nonsteroidal anti-inflammatory drug-induced apoptosis
S. Tsutsumi;T. Gotoh;W. Tomisato;S. Mima.
Cell Death & Differentiation (2004)
AbeM, an H+-Coupled Acinetobacter baumannii Multidrug Efflux Pump Belonging to the MATE Family of Transporters
Xian Zhong Su;Jing Chen;Tohru Mizushima;Teruo Kuroda.
Antimicrobial Agents and Chemotherapy (2005)
NorM of Vibrio parahaemolyticus Is an Na+-Driven Multidrug Efflux Pump
Yuji Morita;Atsuko Kataoka;Sumiko Shiota;Tohru Mizushima.
Journal of Bacteriology (2000)
An Autophagic Flux Probe that Releases an Internal Control
Takeshi Kaizuka;Hideaki Morishita;Yutaro Hama;Satoshi Tsukamoto.
Molecular Cell (2016)
Mechanisms of Action of Corilagin and Tellimagrandin I That Remarkably Potentiate the Activity of β-Lactams against Methicillin-Resistant Staphylococcus aureus
Sumiko Shiota;Masato Shimizu;Jun'ichi Sugiyama;Yuji Morita.
Microbiology and Immunology (2004)
Prostaglandin E2 protects gastric mucosal cells from apoptosis via EP2 and EP4 receptor activation.
Tatsuya Hoshino;Shinji Tsutsumi;Wataru Tomisato;Hyun Jung Hwang.
Journal of Biological Chemistry (2003)
Genetic Evidence for a Protective Role for Heat Shock Factor 1 and Heat Shock Protein 70 against Colitis
Ken Ichiro Tanaka;Takushi Namba;Yasuhiro Arai;Mitsuaki Fujimoto.
Journal of Biological Chemistry (2007)
A Putative Multisubunit Na+/H+ Antiporter from Staphylococcus aureus
Toshiaki Hiramatsu;Kazuyo Kodama;Teruo Kuroda;Tohru Mizushima.
Journal of Bacteriology (1998)
EfrAB, an ABC Multidrug Efflux Pump in Enterococcus faecalis
Eun Woo Lee;M. Nazmul Huda;Teruo Kuroda;Tohru Mizushima.
Antimicrobial Agents and Chemotherapy (2003)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: